ES8703742A1 - Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina - Google Patents

Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina

Info

Publication number
ES8703742A1
ES8703742A1 ES550648A ES550648A ES8703742A1 ES 8703742 A1 ES8703742 A1 ES 8703742A1 ES 550648 A ES550648 A ES 550648A ES 550648 A ES550648 A ES 550648A ES 8703742 A1 ES8703742 A1 ES 8703742A1
Authority
ES
Spain
Prior art keywords
compositions
sustained
medical
preparing
veterinary use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550648A
Other languages
English (en)
Other versions
ES550648A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8703742A1 publication Critical patent/ES8703742A1/es
Publication of ES550648A0 publication Critical patent/ES550648A0/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN AGENTE ACUOSO ESTERIL DE ACCION RETARDADA Y PROLONGADA, DE UN PEPTIDO O DE UNA PROTEINA. COMPRENDE LAS SIGUIENTES OPERACIONES: PRIMERA, SE DISUELVE O SUSPENDE UN PEPTIDO O UNA PROTEINA EN AGUA O EN UNA SOLUCION ACUOSA A UNA TEMPERATURA COMPRENDIDA ENTRE 0 Y 50 GRADOS, MEDIANTE AGITACION O SACUDIMIENTO; SEGUNDA, A LA SUSPENSION FORMADA SE LE AÑADE UN AGENTE GELIFICANTE FISIOLOGICAMENTE COMPATIBLE, A UNA TEMPERATURA COMPRENDIDA ENTRE 0 Y 50 GRADOS, EVENTUALMENTE UN AGENTE DE ISOTONIA APROPIADO, UN TAMPON APROPIADO O UN AGENTE CONSERVANTE APROPIADO EN CUALQUIER ORDEN DE SUCESION, CON AGITACION O SACUDIMIENTO; Y POR ULTIMO, SE ESTERILIZA EL PREPARADO FORMADO. DE APLICACION EN LA PREPARACION DE FARMACOS.
ES550648A 1985-01-05 1986-01-03 Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina Expired ES8703742A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853500268 DE3500268A1 (de) 1985-01-05 1985-01-05 Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Publications (2)

Publication Number Publication Date
ES8703742A1 true ES8703742A1 (es) 1987-03-01
ES550648A0 ES550648A0 (es) 1987-03-01

Family

ID=6259341

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550648A Expired ES8703742A1 (es) 1985-01-05 1986-01-03 Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina

Country Status (14)

Country Link
EP (1) EP0187361A3 (es)
JP (1) JPS61165331A (es)
AU (1) AU586847B2 (es)
DE (1) DE3500268A1 (es)
DK (1) DK2086A (es)
ES (1) ES8703742A1 (es)
FI (1) FI860014A (es)
GR (1) GR860009B (es)
HU (1) HU200422B (es)
NO (1) NO860012L (es)
NZ (1) NZ214686A (es)
PH (1) PH22455A (es)
PT (1) PT81782B (es)
ZA (1) ZA8632B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2661040A (en) * 1949-10-19 1953-12-01 Guldenring Paul Meat grinder
JPH0657658B2 (ja) * 1985-04-11 1994-08-03 住友製薬株式会社 徐放性製剤
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
CA1267602A (en) * 1985-09-10 1990-04-10 Fumio Kakimoto Composition containing tissue plasminogen activator
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
IL86933A (en) * 1987-07-01 1993-07-08 Genentech Inc Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
SE0600091L (sv) * 2006-01-18 2007-04-17 Bows Pharmaceuticals Ag Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
DE102007047040A1 (de) * 2007-10-01 2009-04-16 Fresenius Kabi Deutschland Gmbh Transparentes Kältegel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393264A (en) * 1888-11-20 Sash-holdefl
US3329574A (en) * 1965-04-12 1967-07-04 Schwarz Biores Inc Method and material for selective diffusion
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
US3932624A (en) * 1974-06-17 1976-01-13 Morton-Norwich Products, Inc. Method for prolonging the inhibitory effect of saralasin on angiotensin II
AU513400B2 (en) * 1976-03-04 1980-11-27 Commonwealth Serum Laboratories Commission Biodegradable, sustained release composition
DE3124981A1 (de) * 1981-06-25 1983-01-13 Dr. Ruhland Nachfolger GmbH, 8425 Neustadt Wirkstoffhaltige kollageneinlage zum einfuehren in knochen oder weichteile und verfahren zu deren herstellung
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法

Also Published As

Publication number Publication date
FI860014A (fi) 1986-07-06
JPS61165331A (ja) 1986-07-26
EP0187361A3 (de) 1987-10-21
DE3500268A1 (de) 1986-07-10
GR860009B (en) 1986-04-25
PT81782A (de) 1986-02-01
HU200422B (en) 1990-06-28
DK2086A (da) 1986-07-06
DK2086D0 (da) 1986-01-03
NZ214686A (en) 1989-02-24
PH22455A (en) 1988-09-12
AU5183786A (en) 1986-07-10
ES550648A0 (es) 1987-03-01
EP0187361A2 (de) 1986-07-16
HUT39363A (en) 1986-09-29
ZA8632B (en) 1986-08-27
AU586847B2 (en) 1989-07-27
PT81782B (pt) 1988-02-17
FI860014A0 (fi) 1986-01-02
NO860012L (no) 1986-07-07

Similar Documents

Publication Publication Date Title
EG20401A (en) Process for preparing of veterinary composition for the treatment of gastric acid related deseases in animals
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
IL81358A0 (en) Indolizine derivatives,their preparation and pharmaceutical and veterinary compositions containing them
FR2483926B1 (es)
IL74804A0 (en) Human physiologically active polypeptide,its production and pharmaceutical compositions containing it
NZ266475A (en) Use of recombinant adenovirus of animal origin in making pharmaceutical composition
GR3005399T3 (es)
MY101791A (en) New benzimidazole derivatives
GB2198134B (en) Substituted a-amino acids, their preparation and pharmaceutical compositions containing them
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
IL75536A (en) Crystalline calcium pseudomonate,its preparation and pharmaceutical and veterinary compositions comprising it
ES8503344A1 (es) Un procedimiento para preparar derivados de propinilaminoisoxazol
ES2009215A6 (es) Procedimiento de preparar un derivado de interleucina-1beta.
GR3006091T3 (es)
ES8703742A1 (es) Procedimiento para preparar un agente acuoso esteril de ac- cion retardada y prolongada,de un peptido o de una proteina
IL87181A (en) Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them
IL87871A0 (en) Amino acid derivatives,their manufacture and pharmaceutical compositions containing them
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
HUT41002A (en) Process for preparing anticonvulsives
IL70152A (en) Growth-promoting active peptides,their preparation and pharmaceutical and veterinary compositions containing them
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
EP0275207A3 (en) Pharmaceutical, veterinary and cosmetic compositions and uses
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours